-
Mashup Score: 0VIDEO: Bulevirtide improves quality of life in chronic HDV - 2 year(s) ago
Bulevirtide improved quality of life measures among patients treated for chronic hepatitis D virus, Maria Buti, MD, PhD, of the Hospital Universiario Valle Hebron, told Healio Gastroenterology. In a multicenter, randomized, phase 3 study, researchers evaluated the health-related quality of life benefits as measured by the Hepatitis Quality of Life Questionnaire (HQLQ) following 24 weeks of
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 0Large proportion of undiagnosed anti-HDV positive individuals due to lack of testing - 2 year(s) ago
Hepatitis D, in hepatitis B surface antigen-positive individuals, may remain undiagnosed due to lack of testing, particularly in primary care settings, according to a poster. Worldwide, chronic hepatitis D infection often goes unrecognized, partly because it is considered an orphan disease that professionals do not pay much attention to, Adriana Palom, of the Hospital Universitari Vall
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 3
Assessing hepatitis D virus patients for viremia, as well as expanded screening for HDV antibodies in hepatitis B virus patients, may help further identify active HDV cases, according to a presentation at UEG Week Virtual. “Our study nicely showed that the number of confirmed HDV cases in Austria is low, but potentially underestimated due to a lack of testing for anti-HDV antibodies in HBV
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 0
Forty years after the emergence of HDV, the first anti-HDV therapeutic has been approved by the EMA, indicating the dawn of a new era for this difficult to treat disease
Source: Infectious Disease AdvisorCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 4Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease - 3 year(s) ago
Approximately 5% of individuals infected with hepatitis B virus (HBV) are coinfected with hepatitis D virus (HDV). Chronic HBV/HDV coinfection is associated with an unfavourable outcome, with many patients developing liver cirrhosis, liver failure and eventually hepatocellular carcinoma within 5–10 years. The identification of the HBV/HDV receptor and the development of novel in vitro and animal…
Source: GutCategories: Gastroenterology, Latest HeadlinesTweet-
#GUTImage showing the #HDV life cycle, spreading pathways and drug targets from the paper "Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease" via https://t.co/Af7h9mqTfw #HDV #HepatitisD #livertwitter #viralhepatitis https://t.co/togXWtfHer
-
-
Mashup Score: 0Liver-resident bystander CD8+ T cells contribute to liver disease pathogenesis in chronic hepatitis D virus infection - 3 year(s) ago
The hepatitis D virus (HDV) causes the most severe form of chronic hepatitis, often progressing to cirrhosis within 5-10 years. There is no curative treatment and the mechanisms underlying the accelerated liver disease progression are unknown.
Source: GastroenterologyCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 1Long‐Term Study of Hepatitis Delta Virus Infection at Secondary Care Centers: The Impact of Viremia on Liver‐Related Outcomes - 4 year(s) ago
Background and Aims Hepatitis delta virus (HDV) infection is associated with fast progression to liver cirrhosis and liver complications. Previous studies have, however, been mainly from tertiary ca…
Source: AASLDCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 2Long‐term study of hepatitis D infection at secondary care centers: the impact of viremia on liver‐related outcomes - 4 year(s) ago
Background & aims Hepatitis delta virus (HDV) infection is associated with fast progression to liver cirrhosis and liver complications. Previous studies have though been mainly from tertiary care ce…
Source: AASLDCategories: GastroenterologyTweet
VIDEO: #Bulevirtide improves quality of life in chronic #HDV #NASPGHAN21 @NASPGHAN https://t.co/jugvKFOqWp